Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-22 · accession 0001127602-23-016746 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-22 | DNA | Dmytruk Mark E. | See remarks | S - Sale | $1.50 | -250.0K | 372.5K | -40% | -$375.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-22 | S | D | 250,000 | $1.50 | 372,495 | D | — | — |